One of Clint Eastwood's most underrated directorial efforts features a comeback from The Good the Bad and the Ugly's ...

Former quarterback Eli Manning said in an interview with USA Today on Monday that Giants co-owner John Mara made "the right decision" in maintaining the organization’s leadership despite the 3 ...

Now it will be able to analyze your saliva and do a real-time hormone test. Eli Health, a pioneer in hormone monitoring technology, is launching the Hormometer at CES 2025, starting with cortisol ...

Instead, they are talking about Eli Manning, as, it seems, they have been for most of the last two decades. They are debating whether he should be voted into the Pro Football Hall of Fame when he ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stock picks. Israel Englander has always inspired the investment world by founding ...

Eli Lilly's weight loss medicine recently beat Novo Nordisk's in a head-to-head study. Both companies have plenty more anti-obesity candidates in the pipeline. There are many excellent reasons to ...

On Dec. 9, healthcare giant Eli Lilly announced the approval of a new $15 billion share buyback program and yet another significant dividend increase. For a seventh consecutive year, the company ...

Dec 17 (Reuters) - (This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend approval for Biogen's drug, Leqembi, in paragraph 8 ...

Eli Lilly's robust product portfolio, strategic acquisitions, and innovation-led initiatives drive its strong growth, positioning it well in the weight-loss, immunology, and oncology markets. LLY ...